| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 7.64e-06 | 31 | 82 | 4 | GO:0005310 | |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 7.85e-06 | 10 | 82 | 3 | GO:0016176 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 1.43e-05 | 12 | 82 | 3 | GO:0016175 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 7.24e-05 | 20 | 82 | 3 | GO:0050664 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 3.97e-04 | 35 | 82 | 3 | GO:0043325 | |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 7.34e-04 | 10 | 82 | 2 | GO:0019531 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 7.59e-04 | 477 | 82 | 8 | GO:0022804 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of gram-positive bacterium | 5.80e-07 | 5 | 81 | 3 | GO:0070946 | |
| GeneOntologyBiologicalProcess | NADP catabolic process | 2.02e-06 | 7 | 81 | 3 | GO:0006742 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of fungus | 2.02e-06 | 7 | 81 | 3 | GO:0070947 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst involved in inflammatory response | 9.41e-06 | 11 | 81 | 3 | GO:0060264 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in inflammatory response | 1.62e-05 | 13 | 81 | 3 | GO:0002536 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of bacterium | 3.15e-05 | 16 | 81 | 3 | GO:0070944 | |
| GeneOntologyBiologicalProcess | response to yeast | 4.56e-05 | 18 | 81 | 3 | GO:0001878 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of symbiont cell | 5.40e-05 | 19 | 81 | 3 | GO:0070943 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in defense response | 6.34e-05 | 20 | 81 | 3 | GO:0002679 | |
| GeneOntologyBiologicalProcess | neutrophil mediated cytotoxicity | 7.37e-05 | 21 | 81 | 3 | GO:0070942 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle contraction | 8.51e-05 | 22 | 81 | 3 | GO:0045986 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 8.51e-05 | 22 | 81 | 3 | GO:0050665 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst | 9.76e-05 | 23 | 81 | 3 | GO:0060263 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 1.43e-04 | 497 | 81 | 9 | GO:0002697 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle contraction | 2.65e-04 | 79 | 81 | 4 | GO:0006940 | |
| GeneOntologyBiologicalProcess | reactive oxygen species biosynthetic process | 2.78e-04 | 80 | 81 | 4 | GO:1903409 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol biosynthetic process | 2.92e-04 | 33 | 81 | 3 | GO:0045540 | |
| GeneOntologyBiologicalProcess | regulation of sterol biosynthetic process | 2.92e-04 | 33 | 81 | 3 | GO:0106118 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 3.49e-04 | 35 | 81 | 3 | GO:0045932 | |
| GeneOntologyBiologicalProcess | killing by host of symbiont cells | 4.46e-04 | 38 | 81 | 3 | GO:0051873 | |
| GeneOntologyBiologicalProcess | cholesterol metabolic process | 4.58e-04 | 163 | 81 | 5 | GO:0008203 | |
| GeneOntologyBiologicalProcess | positive regulation of memory T cell differentiation | 5.39e-04 | 9 | 81 | 2 | GO:0043382 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 5.59e-04 | 41 | 81 | 3 | GO:0006691 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 4.55e-05 | 18 | 82 | 3 | GO:0043020 | |
| MousePheno | abnormal angiotensin I-converting enzyme activity | 2.59e-06 | 6 | 72 | 3 | MP:0013254 | |
| MousePheno | increased angiotensin I-converting enzyme activity | 2.59e-06 | 6 | 72 | 3 | MP:0003184 | |
| MousePheno | liver abscess | 4.52e-06 | 7 | 72 | 3 | MP:0003332 | |
| MousePheno | impaired granulocyte bactericidal activity | 1.53e-05 | 10 | 72 | 3 | MP:0005074 | |
| MousePheno | decreased lipid level | SLC25A21 SLC16A1 PREP LPCAT3 DHCR7 NCF1 G6PC2 GRHL3 NCF1C NCF1B LEPR PCK1 PCTP | 7.53e-05 | 727 | 72 | 13 | MP:0014461 |
| MousePheno | abnormal vascular smooth muscle physiology | 8.23e-05 | 140 | 72 | 6 | MP:0005595 | |
| MousePheno | decreased susceptibility to Orthomyxoviridae infection | 1.01e-04 | 18 | 72 | 3 | MP:0020947 | |
| MousePheno | skin lesions | 1.04e-04 | 91 | 72 | 5 | MP:0001212 | |
| MousePheno | abnormal vasoconstriction | 1.25e-04 | 50 | 72 | 4 | MP:0000250 | |
| MousePheno | abnormal blood vessel physiology | 1.81e-04 | 394 | 72 | 9 | MP:0000249 | |
| MousePheno | decreased vasoconstriction | 1.88e-04 | 22 | 72 | 3 | MP:0003026 | |
| MousePheno | increased circulating renin level | 2.15e-04 | 23 | 72 | 3 | MP:0003352 | |
| MousePheno | abnormal vasculature physiology | 2.19e-04 | 404 | 72 | 9 | MP:0031170 | |
| MousePheno | abnormal locomotor activation | 2.75e-04 | 112 | 72 | 5 | MP:0003313 | |
| Domain | Peptidase_S9 | 1.13e-05 | 11 | 78 | 3 | PF00326 | |
| Domain | Peptidase_S9 | 1.13e-05 | 11 | 78 | 3 | IPR001375 | |
| Domain | Pept_S9_AS | 1.03e-04 | 4 | 78 | 2 | IPR002471 | |
| Domain | PRO_ENDOPEP_SER | 1.71e-04 | 5 | 78 | 2 | PS00708 | |
| Domain | - | 2.55e-04 | 6 | 78 | 2 | 2.140.10.30 | |
| Domain | DPPIV_N | 2.55e-04 | 6 | 78 | 2 | PF00930 | |
| Domain | CP2 | 2.55e-04 | 6 | 78 | 2 | PF04516 | |
| Domain | CP2 | 2.55e-04 | 6 | 78 | 2 | IPR007604 | |
| Domain | Peptidase_S9B_N | 2.55e-04 | 6 | 78 | 2 | IPR002469 | |
| Domain | SLC26A | 7.58e-04 | 10 | 78 | 2 | PS01130 | |
| Domain | STAS | 9.24e-04 | 11 | 78 | 2 | PS50801 | |
| Domain | STAS_dom | 9.24e-04 | 11 | 78 | 2 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 9.24e-04 | 11 | 78 | 2 | IPR011547 | |
| Domain | STAS | 9.24e-04 | 11 | 78 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 9.24e-04 | 11 | 78 | 2 | IPR001902 | |
| Domain | - | 9.24e-04 | 11 | 78 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 9.24e-04 | 11 | 78 | 2 | PF00916 | |
| Domain | - | 1.55e-03 | 119 | 78 | 4 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 1.55e-03 | 119 | 78 | 4 | IPR029058 | |
| Domain | MAM_1 | 1.99e-03 | 16 | 78 | 2 | PS00740 | |
| Domain | MAM | 2.25e-03 | 17 | 78 | 2 | SM00137 | |
| Domain | MAM | 2.52e-03 | 18 | 78 | 2 | PF00629 | |
| Domain | MAM_dom | 2.52e-03 | 18 | 78 | 2 | IPR000998 | |
| Domain | MAM_2 | 2.52e-03 | 18 | 78 | 2 | PS50060 | |
| Domain | EPHD | 3.77e-03 | 22 | 78 | 2 | PS51805 | |
| Domain | - | 5.24e-03 | 26 | 78 | 2 | 3.60.10.10 | |
| Domain | TIMP-like_OB-fold | 5.24e-03 | 26 | 78 | 2 | IPR008993 | |
| Domain | Exo_endo_phos | 5.24e-03 | 26 | 78 | 2 | PF03372 | |
| Domain | Endo/exonuclease/phosphatase | 5.65e-03 | 27 | 78 | 2 | IPR005135 | |
| Domain | PHD | 6.15e-03 | 89 | 78 | 3 | SM00249 | |
| Domain | Znf_PHD | 6.54e-03 | 91 | 78 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 7.36e-03 | 95 | 78 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 7.58e-03 | 96 | 78 | 3 | PS01359 | |
| Pathway | REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES | 1.67e-06 | 50 | 57 | 5 | M27282 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 5.18e-06 | 9 | 57 | 3 | MM14524 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 1.60e-05 | 38 | 57 | 4 | MM14519 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 3.45e-05 | 46 | 57 | 4 | MM15837 | |
| Pathway | REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR | 3.58e-05 | 93 | 57 | 5 | M10294 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.35e-04 | 25 | 57 | 3 | MM15269 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 2.48e-04 | 76 | 57 | 4 | MM14526 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 3.43e-04 | 34 | 57 | 3 | MM1399 | |
| Pathway | REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES | 3.74e-04 | 35 | 57 | 3 | MM14944 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | ATP6V0D1 FCGR1A ABCA13 CSNK2B NCF1 TMEM30A CD46 NCF1C NCF1B DYNC1H1 CHRNB4 B4GALT1 | 5.22e-04 | 995 | 57 | 12 | MM14661 |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 1.31e-08 | 3 | 83 | 3 | 27044504 | |
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 1.31e-08 | 3 | 83 | 3 | 18787174 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 24873968 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 22184329 | ||
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 1.31e-08 | 3 | 83 | 3 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 1.31e-08 | 3 | 83 | 3 | 20142487 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 1.31e-08 | 3 | 83 | 3 | 25565313 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 39357591 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 11435342 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 31118934 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 16041040 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 1.31e-08 | 3 | 83 | 3 | 18703411 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 17307863 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 1.31e-08 | 3 | 83 | 3 | 27829407 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 22376231 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 1.31e-08 | 3 | 83 | 3 | 28274989 | |
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 1.31e-08 | 3 | 83 | 3 | 12364355 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 34557202 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 28467721 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 10670582 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 26528554 | ||
| Pubmed | The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. | 1.31e-08 | 3 | 83 | 3 | 19052348 | |
| Pubmed | Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. | 1.31e-08 | 3 | 83 | 3 | 20864666 | |
| Pubmed | Reactive oxygen species delay control of lymphocytic choriomeningitis virus. | 1.31e-08 | 3 | 83 | 3 | 23328631 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 34572995 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 17114280 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 25989352 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 17404617 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 17332431 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 36592568 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 30504842 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 33705493 | ||
| Pubmed | Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. | 1.31e-08 | 3 | 83 | 3 | 23965970 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 15513930 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 15033459 | ||
| Pubmed | Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles. | 1.31e-08 | 3 | 83 | 3 | 20828610 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 20817944 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 36853827 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 23024271 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 21253614 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 15310853 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 31393787 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 10725280 | ||
| Pubmed | Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice. | 1.31e-08 | 3 | 83 | 3 | 34970267 | |
| Pubmed | Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility. | 1.31e-08 | 3 | 83 | 3 | 25689796 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 14993144 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 22050439 | ||
| Pubmed | The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. | 1.31e-08 | 3 | 83 | 3 | 12031896 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 11249873 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 15936744 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 25628043 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 12560337 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 35276443 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 19381132 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 12176908 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 9329953 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 10799876 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 11834706 | ||
| Pubmed | A model of chronic enthesitis and new bone formation characterized by multimodal imaging. | 1.31e-08 | 3 | 83 | 3 | 30045841 | |
| Pubmed | Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease. | 1.31e-08 | 3 | 83 | 3 | 19635825 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 35788118 | ||
| Pubmed | Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation. | 1.31e-08 | 3 | 83 | 3 | 17310103 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 18036262 | ||
| Pubmed | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. | 1.31e-08 | 3 | 83 | 3 | 10678931 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 17167081 | ||
| Pubmed | Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. | 1.31e-08 | 3 | 83 | 3 | 24358335 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 10891396 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 25474113 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 26209274 | ||
| Pubmed | NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. | 1.31e-08 | 3 | 83 | 3 | 11018074 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 9116268 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 20686129 | ||
| Pubmed | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. | 1.31e-08 | 3 | 83 | 3 | 21570954 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 12958309 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 23482812 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 10085000 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 10987289 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 21435178 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 29228045 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 22155727 | ||
| Pubmed | Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. | 1.31e-08 | 3 | 83 | 3 | 24576409 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 26645958 | ||
| Pubmed | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. | 1.31e-08 | 3 | 83 | 3 | 24549323 | |
| Pubmed | NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. | 1.31e-08 | 3 | 83 | 3 | 20881184 | |
| Pubmed | Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. | 1.31e-08 | 3 | 83 | 3 | 19168575 | |
| Pubmed | NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. | 1.31e-08 | 3 | 83 | 3 | 19503084 | |
| Pubmed | Genetic requirement of p47phox for superoxide production by murine microglia. | 1.31e-08 | 3 | 83 | 3 | 11156938 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 10772875 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 27798190 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 20702812 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 26455429 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 15626477 | ||
| Pubmed | NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. | 1.31e-08 | 3 | 83 | 3 | 19077231 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 22319452 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 16895801 | ||
| Pubmed | Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. | 1.31e-08 | 3 | 83 | 3 | 20690191 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 16772302 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 32504071 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 16280459 | ||
| Cytoband | 6q22 | 8.98e-05 | 8 | 83 | 2 | 6q22 | |
| Cytoband | 2q24.3 | 3.81e-04 | 16 | 83 | 2 | 2q24.3 | |
| Cytoband | 7q11.23 | 7.43e-04 | 97 | 83 | 3 | 7q11.23 | |
| GeneFamily | CD molecules|DASH family | 1.26e-04 | 7 | 45 | 2 | 1205 | |
| GeneFamily | Immunoglobulin like domain containing | 1.33e-03 | 193 | 45 | 4 | 594 | |
| GeneFamily | Solute carriers | 2.89e-03 | 395 | 45 | 5 | 752 | |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP | 3.18e-06 | 200 | 82 | 7 | M4668 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.84e-06 | 199 | 82 | 6 | 8a7bccf76fdf0b46854750a0a6a5eade0e14e515 | |
| Drug | Gly-pro-mca | 1.25e-05 | 13 | 82 | 3 | CID000125640 | |
| Drug | 7-dehydrocholesterol | 1.28e-05 | 2 | 82 | 2 | ctd:C016705 | |
| Drug | vildagliptin | 1.28e-05 | 2 | 82 | 2 | ctd:C502012 | |
| Drug | (2S,5S)-1-[(2S)-2-amino-2-cyclopentylacetyl]-5-ethynylpyrrolidine-2-carbonitrile | 1.28e-05 | 2 | 82 | 2 | CID010263908 | |
| Drug | 1,1'-Carbonyl-di-(1,2,4-triazole) | 1.29e-05 | 40 | 82 | 4 | CID004393961 | |
| Drug | acridine orange | 2.44e-05 | 16 | 82 | 3 | CID000062344 | |
| Drug | dAbs | 2.70e-05 | 48 | 82 | 4 | CID000067539 | |
| Drug | SureCN3749646 | 3.84e-05 | 3 | 82 | 2 | CID011530920 | |
| Drug | SureCN3745540 | 3.84e-05 | 3 | 82 | 2 | CID011974437 | |
| Drug | SureCN3749947 | 3.84e-05 | 3 | 82 | 2 | CID011974435 | |
| Drug | ABT-279 | 3.84e-05 | 3 | 82 | 2 | CID016049769 | |
| Drug | Cyanopyrrolidine 38 | 3.84e-05 | 3 | 82 | 2 | CID010932707 | |
| Drug | Cyanopyrrolidine 39 | 3.84e-05 | 3 | 82 | 2 | CID011117606 | |
| Drug | SureCN3748611 | 3.84e-05 | 3 | 82 | 2 | CID011974325 | |
| Drug | Diprolyl-alanine | 3.84e-05 | 3 | 82 | 2 | CID000193559 | |
| Drug | dichlobenil | 5.71e-05 | 21 | 82 | 3 | CID000003031 | |
| Drug | malachite green | 6.60e-05 | 22 | 82 | 3 | CID000011294 | |
| Drug | glycylproline 4-nitroanilide | 7.65e-05 | 4 | 82 | 2 | ctd:C042892 | |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.34e-05 | 199 | 82 | 6 | 6828_UP | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 1.98e-07 | 5 | 81 | 3 | DOID:3265 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 4.31e-06 | 12 | 81 | 3 | DOID:7148 (implicated_via_orthology) | |
| Disease | congenital disorder of glycosylation (is_implicated_in) | 7.44e-06 | 2 | 81 | 2 | DOID:5212 (is_implicated_in) | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 9.85e-04 | 17 | 81 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | arginine measurement | 1.81e-03 | 23 | 81 | 2 | EFO_0020990 | |
| Disease | triglyceride measurement, response to escitalopram, response to citalopram | 2.50e-03 | 27 | 81 | 2 | EFO_0004530, EFO_0006329, EFO_0007871 | |
| Disease | opioid use disorder | 2.74e-03 | 101 | 81 | 3 | EFO_0010702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IPNMYYTFGKDFKQN | 186 | Q86Y25 | |
| NFYGNSMYFVNPASA | 381 | P30926 | |
| VAMDKFGFSLPYVQY | 271 | P15291 | |
| FYEISQIFYGKNMPC | 2131 | Q96N23 | |
| EGTAFNVTMGYKYPP | 16 | P61568 | |
| GYKYFSGKNVLMPSS | 126 | Q96LI9 | |
| NLNGKSQYYIMFGPD | 121 | Q96L12 | |
| VQGYFMLYKNDPVGA | 396 | Q9Y276 | |
| FPFKNYRQAGGDYAM | 2351 | Q7Z2Y8 | |
| MASPKGFFNYLTYFL | 1 | Q5T7R7 | |
| DGFKYNYVFAPLQDM | 3516 | Q86UQ4 | |
| GMKFDRGYISPYFIN | 216 | P10809 | |
| FYNYMMGIEFNPRIG | 216 | Q9UBM7 | |
| AMRPFFGYNFGKYLA | 481 | P35558 | |
| TYMGKFSIDPQYPGA | 91 | P11161 | |
| PITGYMFGKGIYFAD | 451 | Q9UGN5 | |
| FNLNPALTMIGKYFY | 126 | P53985 | |
| FKYFLQGMGYIPSAS | 306 | Q9UGV2 | |
| YFGFYYNVKNMIPVN | 186 | Q9BQT8 | |
| FYGTANMTYLQPKSG | 251 | P58181 | |
| VPANGTYEFGYQMHF | 111 | P15529 | |
| YPNLNGLYIFGDFMS | 486 | Q96JK4 | |
| YKMNRLYLTPDGFFF | 241 | Q2M2W7 | |
| YSNIMISQFGFPYAN | 311 | Q9UBQ6 | |
| FGSFDQTMKGNSYLP | 3251 | Q5CZC0 | |
| EKPYLFSLGYDSNMG | 1076 | Q63HM2 | |
| SYKYPGMFIALSKNG | 171 | P08620 | |
| VTGYFPSMYLQKSGQ | 271 | P14598 | |
| AFGFMVPDVKYNEAY | 686 | Q9H8E8 | |
| EFMITFPYGYHAGFN | 266 | O75164 | |
| SYFYGAFLVGPQFSM | 191 | Q6P1A2 | |
| ALYGPKYTFFNNVLM | 471 | Q9UL01 | |
| KYQFSLYPIFMEGVG | 806 | P48357 | |
| YYISNEYKGMPGGRN | 416 | P27487 | |
| TMQKAAYYENPGLFG | 16 | P31249 | |
| AFAKSQPNMYGLAAY | 301 | P31249 | |
| DVTGYFPSMYLQKSG | 271 | A6NI72 | |
| DVTGYFPSMYLQKSG | 246 | A8MVU1 | |
| PNADRSGSKEGFYMY | 786 | Q7Z553 | |
| DGKGMFYNSYPQQDG | 181 | P48147 | |
| VFMYYFDNPGGQIPS | 171 | Q9UKL6 | |
| YAKYESQTSFGSMYP | 506 | Q9P0U4 | |
| YFFLGMYKQAEAAGF | 101 | A0AVF1 | |
| GESPMAYLNKGQFYP | 246 | Q8TE85 | |
| PGDSTMTYLNKGQFY | 266 | Q9NZI5 | |
| YYLGSVAMQAEKFPS | 806 | Q6V1X1 | |
| SYGLAYSLMKFFTGP | 51 | Q9HCJ1 | |
| QMLEKYQQGDFGYCP | 96 | P67870 | |
| AYYTFLNFMSNVGDP | 21 | Q9NQR9 | |
| EKSFEGNVFMYYGLS | 111 | Q9NV96 | |
| PGLQLYFSFYMGSKT | 221 | P12314 | |
| MANAKFNYGFEYLGV | 1861 | Q14204 | |
| FMSYFPRGLKYQEGG | 106 | P40121 | |
| NGLKLKYYYMPFGSG | 426 | P22680 | |
| YLYKDGEMIPYGFNN | 246 | Q86VF2 | |
| LMPYTNYTFDFKGII | 476 | Q9ULM6 | |
| KNDKQMSYGFLFPPY | 671 | Q13822 | |
| PFYMGFIPAMQDNYA | 281 | Q6J272 | |
| NEYLMGKFPFFRGSY | 146 | Q9C009 | |
| LYMGQIKGAFGTYEP | 16 | Q5J8X5 | |
| VTYQNAMSGGAPYYF | 656 | Q15262 | |
| YKTIYFFGDKTMPGG | 201 | O15305 | |
| GEYNIFKYAPMFESN | 36 | Q8TC56 | |
| GVVLFTMLYGQFPFY | 261 | Q8N2I9 | |
| KSGMYEYYASEGQNP | 126 | A6NHR9 | |
| PKAVAFGEMGLDYSY | 586 | Q93075 | |
| SAQNIYSFGFGKAMP | 201 | Q8IWB6 | |
| EFSAPSYLMGYNKSL | 181 | Q96RN1 | |
| GDFMLNQYTKTFGYP | 56 | Q16773 | |
| GPGSLDTFMQYFYGQ | 321 | Q8NA69 | |
| DQGFQFSYKEMLIGY | 771 | Q7Z745 | |
| FYGTLIFMYLQPKSN | 251 | Q8NH85 | |
| VMYGFKGVSPSNYEK | 316 | P54922 | |
| KAGDGPQFQFTLMSY | 236 | Q9UNK9 | |
| TAFFMYNAFGKPFET | 116 | P58418 | |
| KPAITYGTRGNSYFM | 236 | Q96KN2 | |
| FFYPNMGGVESHIYQ | 41 | P37287 | |
| GGPTEDKGFYYQQMS | 721 | Q8TBB6 | |
| FVYAQFDGIMGLAYP | 171 | P20142 | |
| VFKVSLVSGMPFYGY | 101 | O60673 | |
| LFTQYMPYTLAGGKA | 456 | Q8N2H3 | |
| AGDFYYMAGNKDPVT | 86 | Q9UGU0 | |
| MFQTDADFYQQYGPG | 746 | Q13105 | |
| AMTYYGNLDSEKPIF | 616 | Q8TE54 | |
| TDMLSNFGYPGYQSK | 166 | P35625 | |
| MSFFPELYFNVDNGY | 1 | P61421 | |
| FNRTAMPYGGYEKAS | 221 | Q9NP98 |